Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography
RJ Hicks,
WH Herman,
V Kalff,
E Molina,
ER Wolfe,
G Hutchins,
and
M Schwaiger
Department of Internal Medicine, University of Michigan Hospitals, Ann Arbor 48109-0028.
Meaning interpretation of metabolic images obtained by positron emission tomography for evaluation of cardiac disease requires a knowledge of the normal variation in regional myocardial substrate metabolism. Recent studies with fluorine-18 (F-18) fluorodeoxyglucose suggest inhomogeneity of myocardial glucose metabolism in the normal human heart, which may relate to substrate availability. Therefore, quantitative evaluation of myocardial oxidative metabolism and glucose metabolism, as derived by dynamic positron emission tomography with carbon-11 (C-11) acetate and F-18 fluorodeoxyglucose, was performed in nine healthy male volunteers. All were studied under tightly controlled metabolic conditions of hyperinsulinemic-euglycemic clamping with and without a concurrent lipid emulsion infusion. Significant inhomogeneity of regional glucose metabolism was noted although it was less than that described under fasting conditions. Glucose utilization was 13% lower in the septum compared with the lateral wall both without and with lipid infusion (0.34 vs. 0.39 mumol/g per min, respectively, p less than 0.05; and 0.33 vs. 0.38 mumol/g per min, respectively, (p less than 0.05). Relatively decreased septal glucose utilization could not be explained by decreased metabolic demand because C-11 clearance constants were marginally higher in the septum than in the lateral wall in both studies (0.055 vs. 0.054 per min, respectively, p = NS; and 0.061 vs. 0.056 per min, respectively, p less than 0.05). Relatively decreased septal glucose utilization could reflect regional variation in substrate use and possible preferential free fatty acid utilization by the septum. These data provide a useful framework for assessing altered cardiac metabolism in disease and support standardization of metabolic conditions during metabolic imaging with positron emission tomography.
This article has been cited by other articles:

|
 |

|
 |
 
N. Ohte, K. Kurokawa, A. Iida, H. Narita, S. Akita, K. Yajima, H. Miyabe, J. Hayano, and G. Kimura
Myocardial Oxidative Metabolism in Remote Normal Regions in the Left Ventricles with Remodeling After Myocardial Infarction: Effect of {beta}-Adrenoceptor Blockers
J. Nucl. Med.,
June 1, 2002;
43(6):
780 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. van der Weerdt, L. J. Klein, R. Boellaard, C. A. Visser, F. C. Visser, and A. A. Lammertsma
Image-Derived Input Functions for Determination of MRGlu in Cardiac 18F-FDG PET Scans
J. Nucl. Med.,
November 1, 2001;
42(11):
1622 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.L Gerber, F.F Ordoubadi, W Wijns, J.-L.J Vanoverschelde, M.J Knuuti, M Janier, P Melon, P.K Blanksma, A Bol, J.J Bax, et al.
Positron emission tomography using18F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Action Multicenter study on use of18F-fluoro-deoxyglucose Positron Emission Tomography for the Detection of Myocardial Viability
Eur. Heart J.,
September 2, 2001;
22(18):
1691 - 1701.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. vom Dahl, O. Muzik, E. R. Wolfe Jr, C. Allman, G. Hutchins, and M. Schwaiger
Myocardial Rubidium-82 Tissue Kinetics Assessed by Dynamic Positron Emission Tomography as a Marker of Myocardial Cell Membrane Integrity and Viability
Circulation,
January 15, 1996;
93(2):
238 - 245.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Th. Locher, L. D. Frey, K. Seybold, and H. Jenzer
Myocardial 18F-FDG-PET: Experiences with the Euglycemic Hyperinsulinemic Clamp Technique
Angiology,
April 1, 1995;
46(4):
313 - 320.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Iozzo, P. Chareonthaitawee, M. Di Terlizzi, D. J. Betteridge, E. Ferrannini, and P. G. Camici
Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans
Am J Physiol Endocrinol Metab,
May 1, 2002;
282(5):
E1163 - E1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|